BioSpace: Biotech, Pharmaceutical and Clinical Research News
2010年12月11日 · 2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.
BioSpace - BioSpace
2024年7月31日 · BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
About Us - BioSpace
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
China - BioSpace
5 天之前 · BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest …
5 天之前 · The members of BioSpace’s NextGen Class of 2025 are not afraid of a challenge, diving into and tackling hurdles in some of biopharma’s most competitive spaces.. For 11 years, BioSpace has highlighted the most anticipated new biopharma startups from across the U.S.This year’s class, selected from companies that announced initial, seed or series A rounds between …
Approvals - BioSpace
2024年12月23日 · The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion in 2023. It’s welcome good news for Vertex following last week’s subpar clinical results for its non-opioid analgesic.
Companies - BioSpace
3 天之前 · BioSpace’s annual Best Places to Work list demonstrates a company’s desirability in the recruitment marketplace. Each organization’s merits are considered with particular emphasis on culture, career growth and development opportunities, leadership and innovation.
The Weekly - BioSpace
2024年12月11日 · GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment model; Eli Lilly and Novo Nordisk pump new funds into manufacturing; and AbbVie makes a Cerevel comeback while uniQure clears a path toward …
A Cautiously Sunny Outlook for Biopharma in 2025 - BioSpace
4 天之前 · After a challenging first half of 2024, the number of clinical trials is beginning to increase, and Advarra expects ~2% growth through 2027. There are a few therapeutic areas that will continue to garner the majority of investment dollars, including oncology, which has a distinct lead over all other areas.. The pipeline will continue to grow, particularly in immuno-oncology …
Big Pharma Rushes to China for Deal Prospecting Despite …
4 天之前 · In the final weeks of 2024, pharmaceutical companies struck a handful of deals with China-based biotechs, with antibody-drug conjugates high on the wish list. The flurry of activity reflects a potential gold mine for Western companies as China’s data become more trustworthy, experts told BioSpace ...